MAP kinases in the immune response

Annual Review of Immunology

Volumn 20, Issue , 2002, Pages 55-72

  Dong, Chen ^a   Davis, Roger J ^a   Flavell, Richard A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

ERK; Helper T Cells; Innate immunity; JNK; p38

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANISOMYCIN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; ENDOTOXIN; FLAGELLIN; GAMMA INTERFERON; GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; LYMPHOTOXIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PEPTIDOGLYCAN; PERFORIN; PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

APOPTOSIS; CYTOKINE PRODUCTION; CYTOTOXICITY; HELPER CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-12; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOCYTE ACTIVATION; MAP KINASE KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-TYROSINE KINASES; PROTEINS; RAC GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0036221384     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.20.091301.131133     Document Type: Review

References (90)

1. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
2. Emerging targets for anti-inflammatory therapy
3. Signal transduction by the JNK group of MAP kinases
4. Mammalian MAP kinase signaling cascades
5. Selection of the T cell repertoire
6. MAP-kinase signaling pathways in T cells
7. Signal transduction by MAP kinases in T lymphocytes
8. Toll signaling pathways in the innate immune response
9. A conserved p38 mitogen-activated protein kinase pathway regulates Drosophila immunity gene expression
10. A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila
11. Innate immunity: The virtues of a nonclonal system of recognition
12. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
13. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
14. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
15. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
16. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
17. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
18. A Toll-like receptor recognizes bacterial DNA
19. Unresponsiveness of MyD88-deficient mice to endotoxin
20. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways
21. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
22. MyD88, an adapter protein involved in interleukin-1 signaling
23. MyD88: An adapter that recruits IRAK to the IL-1 receptor complex
24. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling
25. TRAF6 is a signal transducer for interleukin-1
26. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
27. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
28. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production
29. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice
30. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis
31. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
32. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology
33. Identification and characterization of protein products of the cot oncogene with serine kinase activity
34. Structure and transforming potential of the human cot oncogene encoding a putative protein kinase
35. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tp12/ERK-dependent pathway
36. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression
37. Deficiency of the stress kinase p38alpha results in embryonic lethality: Characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells
38. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis
39. JNK2 and IKKbeta are required for activating the innate response to viral infection
40. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis
41. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival
42. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines
43. Control of T helper cell differentiation - In search of master genes
44. Lineage commitment in the immune system: The T helper lymphocyte grows up
45. Lymphocyte response and cytokines
46. Signal transduction by the TCR for antigen
47. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells
48. Blocked Ras activation in anergic CD4+ T cells
49. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy
50. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice
51. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation
52. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway
53. IL-18-stimulated GADD45β required in cytokine-induced, but not TCR-induced, IFNγ production
54. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-gamma expression
55. Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells
56. The proximal regulatory element of the interferon-g promoter mediates selective expression in T cells
57. Memory and effector, but not naive T cells, express transcriptional activity under the control of two IFNg promoter elements
58. Regulation of the activity of IFN-γ promoter elements during Th cell differentiation
59. Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice
60. Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation
61. Defective T cell differentiation in the absence of Jnk1
62. + T cells to effector Th1 and Th2 cells
63. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development
64. + T cells to Th1 cells requires MAP kinase JNK2
65. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway
66. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation
67. JNK1 is required for T cell-mediated immunity against Leishmania major infection
68. Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45)
69. JNK inhibits targeting of protein phosphatase calcineurin to NFATc1
70. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation
71. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development
72. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2
73. JNK is required for effector T-cell function but not for T-cell activation
74. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency
75. Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation
76. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK
77. GADD45-gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector T(H)1 cells
78. Gadd45gamma is dispensable for normal mouse development and T-cell proliferation
79. Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells
80. The JNK pathway regulates the in vivo deletion of immature CD4(+)CD8(+) thymocytes
81. Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT)
82. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
83. JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells
84. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death
85. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1
86. Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter
87. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression
88. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M
89. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage
90. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases